http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105524034-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-16 |
| filingDate | 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105524034-B |
| titleOfInvention | Preparation, pharmacological action and the application for treating cerebral ischemia of coumarin derivative |
| abstract | The present invention relates to a kind of coumarin derivatives 7 for treating cerebral ischemia, 8 hydroxyl, 4 trifluoromethyl benzo pyrans, 2 ketone (7,8 dihydroxy, 4 trifluoromethyl 2H chromen, 2 one) preparation and its molecular pharmacology mechanism and cerebral ischemia animal model etc. pharmacodynamic study, and the galenic pharmacy research suitable for cerebral ischemia treatment.The pharmacological mechanism of the reactive compound is clear, and the clinical application that effectively can be used for treating cerebral ischemia is determined for treating cerebral ischemic model. |
| priorityDate | 2015-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 211.